Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00556036 · ClinicalTrials.gov registry record
Hormone Dynamics and Bone Mineral Density in Anorexia Nervosa v. Hypothalamic Amenorrhea
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 61
- Enrollment target
NCT00556036: Completed study, sponsored by Massachusetts General Hospital.
NCT00556036 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 61 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00556036 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 61 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the hormone dynamics in women with anorexia nervosa and hypothalamic amenorrhea is related to bone loss in those populations.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2006-03 |
| Est. Completion | 2009-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00556036
The ClinicalTrials.gov registry entry for NCT00556036 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00556036 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00556036 about?
NCT00556036 is a clinical study titled "Hormone Dynamics and Bone Mineral Density in Anorexia Nervosa v. Hypothalamic Amenorrhea". The purpose of this study is to determine whether the hormone dynamics in women with anorexia nervosa and hypothalamic amenorrhea is related to bone loss in those populations.
What is the current status of trial NCT00556036?
This trial is currently completed. The enrollment target is 61 participants. The study started on 2006-03. Estimated completion is 2009-03.
Who is sponsoring clinical trial NCT00556036?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.